STAT+: Senate panel advances bill to ban some Chinese biotechs, with Sen. Paul taking up industry’s cause
WASHINGTON — A Senate panel today passed a bill aimed at preventing certain Chinese companies…
Category: Prescription Politics
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
STAT+: Drug middlemen catch flak at another congressional hearing
Drug middlemen once again were on the hot seat at a congressional hearing on Wednesday….
Opinion: Fixing price instability can improve access to affordable prescription drugs
The high cost of prescription drugs is a very real problem in the United States….
More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows
WASHINGTON — Seventy-two senators and 302 members of the House of Representatives cashed a check…
Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds
WASHINGTON — State lawmakers in Oregon have tried to lower high drug prices from nearly…
Opinion: Discarded drugs: a wasteful and costly problem that requires whole-of-government approaches
Controlling the rising costs of pharmaceuticals, particularly those administered by physicians, has been a top…
Opinion: Eliminating buprenorphine training for doctors won’t solve the overdose epidemic
Before the Covid-19 pandemic struck, the U.S. was making some headway in fighting the drug…
STAT+ Conversations: How pharma is influencing the 2020 election
Editor’s note: A livestream of this conversation will be embedded above at 1 p.m. ET. …
Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
WASHINGTON — The world’s biggest drug makers and their trade groups have cut checks to…